MarketBeat
01 Aug 2026, 03:05 UTC · 6w ago
Verdict
Headline takes no side. We score SYK +0.80 across five claims — strongly bullish.
+0.80strongly bullish
More positive than 88% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
Stryker reported 9% organic sales growth and 17.9% adjusted EPS growth for Q2 2026.
More positive than 91% of claims this week
The company narrowed its full-year organic net sales growth guidance to 8.3% to 9.3% and adjusted EPS to $14.95 to $15.10.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 85% of claims this week
Adjusted operating margins increased by 170 basis points to 27.4% of sales.
More positive than 77% of claims this week
U.S. vascular organic sales declined 6.7% due to an operational disruption in the Peripheral Vascular business.
More negative than 72% of claims this week
Mako robotic installations achieved record second-quarter levels in both U.S. and international markets.
More positive than 66% of claims this week
Which stocks this story touches
More positive than 88% of ticker scores this week
Strong Q2 organic sales and EPS growth, recovery from cybersecurity issues, and record Mako installations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Invezz
4h ago
−13.5%
Price is moving against the score
$281.87 vs $325.70 close before publication (Jul 31) · not market-adjusted
SYK chart →
